Shenep et al identified risk factors for central line-associated bloodstream infection (CLABSI) in pediatric with cancer who are receiving total parenteral nutrition (TPN). This can help to identify a patient who may benefit from more aggressive management. The authors are from St. Jude Children's Hospital and the University of Melbourne.